ARTICLE | Company News
Emergent BioSolutions, Mapp Biopharmaceutical, Zalgen Labs, Ben-Gurion University of the Negev, NIH, Public Health Agency of Canada, Scripps Research Institute,
March 31, 2014 7:00 AM UTC
NIH's National Institute of Allergy and Infectious Disease (NIAID) awarded a consortium led by Scripps a five-year grant worth up to $28 million to develop immunotherapies for filoviruses and arenavir...